ArticleJAAD international2022
Patterns and barriers of teledermatology in resource-limited settings in COVID-19 pandemic: A descriptive cross-sectional survey of Nepalese dermatologists.
Article in JAAD international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The COVID-19 pandemic has limited in-person consultations and disturbed easy health care access. Teledermatology (Td) is used to provide services in such situations. Objective: To find the pattern and barriers of Td during the COVID-19 pandemic in resource-limited settings. Methods: An online survey focused on dermatologists and residents in dermatology in Nepal was conducted. The online form with the prepared questionnaire was sent to the potential participants. Results: A total of 86 responses were received, with 60% response rate. Approximately 62.8% ( Limitations: A small sample size and associated technical difficulties. Conclusion: Td has proven to be an excellent tool; however, it may never replace the in-person consultation. A newer guideline must be prepared to regulate Td in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.